Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients | MicrobiomeTrials← Back to trialsNCT06388642
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-03-07Est. Completion: 2024-10-28
Enrollment target: 28 participants Locations- CLINUVEL Site, Leuven, Belgium
- CLINUVEL Site, Rotterdam, Netherlands
Other microbiome trials you might be interested in
Erythropoietic Protoporphyria
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in pa…
Birmingham, United StatesCompleted Jun 2028
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
The goal of this expanded access program is to provide bitopertin to patients with EPP and XLP who have no satisfactory …
Miami, United States